NCT04997252 2024-03-18An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate CancerZhujiang HospitalPhase NA Unknown50 enrolled